骨転移(Bone Metastasis):世界の治験レビュー(2015年上半期版)

◆英語タイトル:Bone Metastasis Global Clinical Trials Review, H1, 2015
◆商品コード:GDHC2565CTIDB
◆発行会社(調査会社):GlobalData
◆発行日:2015年2月18日
◆ページ数:179
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥550,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD7,500 ⇒換算¥825,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当調査レポートでは、世界における骨転移(Bone Metastasis) 治療の臨床試験動向について調査・分析し、アジア太平洋/欧州/北米/中南米の主要国における治験件数、段階(フェーズ)別の治験件数、進捗状況別の治験件数、治験目標の達成状況、有望な薬剤、治験関連の最新ニュース、代表的な企業・大学・研究機関における治験概要、代表的な治験のプロファイルなどのデータをまとめてお届けいたします。

・イントロダクション
  - 骨転移(Bone Metastasis)
  - 当レポートの概要
・骨転移(Bone Metastasis):各地域別治験状況
  - 各国の治験件数及び平均被験者数
   アジア太平洋の主要国における治験件数
   欧州の主要国における治験件数
   北米の主要国における治験件数
   中東・アフリカの主要国における治験件数
   中南米の主要国における治験件数
・G7諸国での治験件数
・G7諸国での治験件数:段階別
・G7諸国での治験件数:進捗状況別
・段階(フェーズ)別の治験件数:進行中の治験(段階別)
・進捗状況別の治験件数
・治験目標の達成状況
・未完了の治験件数
・一定期間に採用された被験者
・スポンサーの種類別治験件数
・有望なスポンサー
・有望な薬剤
・治験のプロファイル
  - 代表的な企業における治験概要
  - 代表的な大学・研究機関における治験概要
・5つの代表的な治験のプロファイル
【レポートの概要】

Bone Metastasis Global Clinical Trials Review, H1, 2015

Summary

GlobalData’s clinical trial report, “Bone Metastasis Global Clinical Trials Review, H1, 2015″ provides data on the Bone Metastasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bone Metastasis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bone Metastasis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Bone Metastasis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Bone Metastasis to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Bone Metastasis to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Bone Metastasis 25
Subjects Recruited Over a Period of Time 30
Clinical Trials by Sponsor Type 31
Prominent Sponsors 32
Top Companies Participating in Bone Metastasis Therapeutics Clinical Trials 33
Prominent Drugs 34
Clinical Trial Profiles 35
Clinical Trial Overview of Top Companies 35
Novartis AG 35
Clinical Trial Overview of Novartis AG 35
Amgen Inc. 41
Clinical Trial Overview of Amgen Inc. 41
F. Hoffmann-La Roche Ltd. 43
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 43
Bayer AG 45
Clinical Trial Overview of Bayer AG 45
AstraZeneca PLC 47
Clinical Trial Overview of AstraZeneca PLC 47
Merck & Co., Inc. 48
Clinical Trial Overview of Merck & Co., Inc. 48
Pfizer Inc. 49
Clinical Trial Overview of Pfizer Inc. 49
AbbVie Inc. 50
Clinical Trial Overview of AbbVie Inc. 50
Galil Medical Ltd. 51
Clinical Trial Overview of Galil Medical Ltd. 51
Exelixis, Inc. 52
Clinical Trial Overview of Exelixis, Inc. 52
Clinical Trial Overview of Top Institutes / Government 53
University of Texas M. D. Anderson Cancer Center 53
Clinical Trial Overview of University of Texas M. D. Anderson Cancer Center 53
University Health Network 54
Clinical Trial Overview of University Health Network 54
National Cancer Institute 55
Clinical Trial Overview of National Cancer Institute 55
SWOG 56
Clinical Trial Overview of SWOG 56
West China Hospital 57
Clinical Trial Overview of West China Hospital 57
Washington University School of Medicine 58
Clinical Trial Overview of Washington University School of Medicine 58
Massachusetts General Hospital 59
Clinical Trial Overview of Massachusetts General Hospital 59
Radiation Therapy Oncology Group 60
Clinical Trial Overview of Radiation Therapy Oncology Group 60
Sun Yat-sen University 61
Clinical Trial Overview of Sun Yat-sen University 61
Memorial Sloan Kettering Cancer Center 62
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 62
Five Key Clinical Profiles 63
Appendix 177
Abbreviations 177
Definitions 177
Research Methodology 178
Secondary Research 178
About GlobalData 179
Contact Us 179
Disclaimer 179
Source 179

List of Tables
Bone Metastasis Therapeutics, Global, Clinical Trials by Region, 2015* 7
Bone Metastasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Bone Metastasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Bone Metastasis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Bone Metastasis Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Bone Metastasis Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Bone Metastasis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13
Bone Metastasis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14
Proportion of Bone Metastasis to Oncology Clinical Trials, G7 Countries (%), 2015* 15
Bone Metastasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Bone Metastasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Bone Metastasis to Oncology Clinical Trials, E7 Countries (%), 2015* 18
Bone Metastasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Bone Metastasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Bone Metastasis Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Bone Metastasis Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Bone Metastasis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Bone Metastasis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Bone Metastasis Therapeutics, Global, Suspended Clinical Trials, 2015* 25
Bone Metastasis Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26
Bone Metastasis Therapeutics, Global, Terminated Clinical Trials, 2015* 27
Bone Metastasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 30
Bone Metastasis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 31
Bone Metastasis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 32
Bone Metastasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 33
Bone Metastasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 34
Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 35
Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2015* 41
Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 43
Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 45
Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2015* 47
Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015* 48
Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 49
Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2015* 50
Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Galil Medical Ltd., 2015* 51
Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Exelixis, Inc., 2015* 52
Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Texas M. D. Anderson Cancer Center, 2015* 53
Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2015* 54
Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015* 55
Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by SWOG, 2015* 56
Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by West China Hospital, 2015* 57
Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2015* 58
Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2015* 59
Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Radiation Therapy Oncology Group, 2015* 60
Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2015* 61
Bone Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2015* 62

List of Figures
Bone Metastasis Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Bone Metastasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Bone Metastasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Bone Metastasis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Bone Metastasis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Bone Metastasis Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Bone Metastasis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13
Bone Metastasis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14
Proportion of Bone Metastasis to Oncology Clinical Trials, G7 Countries (%), 2015* 15
Bone Metastasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Bone Metastasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Bone Metastasis to Oncology Clinical Trials, E7 Countries (%), 2015* 18
Bone Metastasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Bone Metastasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Bone Metastasis Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Bone Metastasis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Bone Metastasis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Bone Metastasis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Bone Metastasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 30
Bone Metastasis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 31
Bone Metastasis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 32
Bone Metastasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 33
Bone Metastasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 34
GlobalData Methodology 178

【レポートのキーワード】

骨転移(Bone Metastasis)、治験、臨床試験、治験、治療薬

★調査レポート[骨転移(Bone Metastasis):世界の治験レビュー(2015年上半期版)] (コード:GDHC2565CTIDB)販売に関する免責事項を必ずご確認ください。
★調査レポート[骨転移(Bone Metastasis):世界の治験レビュー(2015年上半期版)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆